Acute and Chronic Performance Evaluation of a Novel Epicardial Pacing Lead Placed by Percutaneous Subxiphoid Approach in a Canine Model

  title={Acute and Chronic Performance Evaluation of a Novel Epicardial Pacing Lead Placed by Percutaneous Subxiphoid Approach in a Canine Model},
  author={Roy M. John and Kevin L. Morgan and Lucas H. Brennecke and Michael E. Benser and Pierre Jais},
  journal={Circulation: Arrhythmia and Electrophysiology},
Background—Endovascularly implanted leads risk vascular injury and endocarditis, and can be difficult to locate in desired positions for LV pacing. We evaluated the acute and long-term stability, electric performance and histopathology of a percutaneously placed intrapericardial lead (IPL). Methods and Results—Twelve adult mongrel dogs underwent defibrillator implants incorporating IPLs. Successful uncomplicated percutaneous implantation of an IPL was achieved in all. Early fluoroscopic shift… 

Figures from this paper

Feasibility of An Entirely Extracardiac, Minimally Invasive,Temporary Pacing System.
Results support the feasibility for this completely extracardiac pacing method in a heterogeneous patient population, using a minimally invasive, parasternal, delivery approach and with adequate sensing and thresholds suited for temporary pacing.
Minimally Invasive Implantation of a Micropacemaker Into the Pericardial Space
A novel micropacemaker system allows cardiac pacing without entering the vascular space or surgical exposure of the heart.
Epicardial approach for cardiac electrophysiology procedures
This work will review the indications and rationale for various epicardial procedures, the anatomy of the pericardium as well as the frequently‐used epicardia access techniques, and the optimal approaches and methodologies for epicardials mapping and ablation and the impact of epicardian fat.
Leadless cardiac pacing systems: current status and future prospects
This review will cover the current status of leadless pacemaker technology, available safety and efficacy outcomes, current area of indication, and end-of-life management, and future perspectives for clinical practice and new pacing modalities are discussed.
Importance of Right Ventricular and Left Ventricular Lead Placement in Cardiac Resynchronisation Therapy
Having a better insight on the means to achieve the optimal technique and the different approaches suitable for selected, difficult cases might help in increasing the number of adequate responders.
Interventional Pericardiology
The field of “interventional pericardiology” is the focus of this chapter and can provide a unique and precious opportunity to enhance patient management in such situations from a diagnostic and therapeutic aspect.
Device Therapy in the Heart Failure
The most common cause of SCD is the degeneration of ventricular tachycardia to ventricular fibrillation, although pulseless electrical activity and bradyarrhythmias account for up to one-third of cases.
An Overview on the Considerations for the Planning of Nonclinical Necropsies for Medical Device Studies
This article serves as a primer of key considerations for the approach and conduct of “nontoxicological” studies, defined as studies involving animal models of deployment or implantation of medical devices as well as surgical animal models.
Heart Failure
The Future of Percutaneous Epicardial Interventions.


Epicardial Interventions in Electrophysiology
The anatomy of the epicardial space is discussed initially, because this provides a basis for a review of the relevant imaging aspects and the technique of accessing the space, initially developed for drainage of pericardial effusions by pericardiocentesis and subsequently modified for accessing a normal pericARDial space, is outlined.
Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict
  • M. PostW. Budts M. Gewillig
  • Medicine
    Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
  • 2011
A high incidence of epicardial lead failures is found in patients with congenital heart disease and it is difficult to predict this potentially life-threatening complication.
An entirely subcutaneous implantable cardioverter-defibrillator.
In small, nonrandomized studies, an entirely subcutaneous ICD consistently detected and converted ventricular fibrillation induced during electrophysiological testing and successfully detected and treated all 12 episodes of spontaneous, sustained ventricular tachyarrhythmia.
Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads.
The fibrosis associated with endocardial ICD leads and the cumulative acute damage produced bydefibrillation discharges may explain changes in the defibrillation and pacing thresholds and the difficulty of lead extraction that can be encountered with transvenous ICD systems.
Epicardial ventricular tachycardia ablation a multicenter safety study.
Epicardial Ablation for Ventricular Tachycardia: A European Multicenter Study
In experienced centers, epicardial ablation of VT has an acceptable risk and favorable outcome and in selected patients, it is reasonable to consider as a first-line ablation approach.
Intrapericardial and Retrocardial Implantation of Implantable Cardioverter-Defibrillator Lead in a Child with Type 3 Long QT Syndrome
A 6-year-old girl with type 3 long QT syndrome was safely and successfully implanted with an implantable cardioverter-defibrillator (ICD) system, and administration of a beta-blocker in addition to atrial pacing almost completely eliminated the patient's life-threatening arrhythmia attacks.
Subcutaneous Implantable Cardioverter Defibrillator
This review will examine the development of the subcutaneous ICD, its advantages, limitations, and potential clinical role in the treatment of ventricular tachyarrhythmias and prevention of SCD.